Akio Fujii

8.0k total citations · 7 hit papers
79 papers, 6.7k citations indexed

About

Akio Fujii is a scholar working on Organic Chemistry, Molecular Biology and Surgery. According to data from OpenAlex, Akio Fujii has authored 79 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Organic Chemistry, 20 papers in Molecular Biology and 15 papers in Surgery. Recurrent topics in Akio Fujii's work include Asymmetric Hydrogenation and Catalysis (11 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Carbohydrate Chemistry and Synthesis (10 papers). Akio Fujii is often cited by papers focused on Asymmetric Hydrogenation and Catalysis (11 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Carbohydrate Chemistry and Synthesis (10 papers). Akio Fujii collaborates with scholars based in Japan, Switzerland and United States. Akio Fujii's co-authors include Ryōji Noyori, Shohei Hashiguchi, Takao Ikariya, Nobuyuki Uematsu, Karl‐Josef Haack, Jun Takehara, Mikiko Sodeoka, TOMOHISA TAKITA, Emiko Hagiwara and HAMAO UMEZAWA and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Cancer.

In The Last Decade

Akio Fujii

76 papers receiving 6.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Asymmetric Transfer Hydrogenation of Aromatic Ketones Catalyzed by Chiral Ruthenium(II) Complexes

1995 1.1k citations Akio Fujii et al. profile →
Ruthenium(II)-Catalyzed Asymmetric Transfer Hydrogenation of Ketones Using a Formic Acid−Triethylamine Mixture

1996 1.0k citations Akio Fujii et al. profile →
The Catalyst Precursor, Catalyst, and Intermediate in the Ru^II‐Promoted Asymmetric Hydrogen Transfer between Alcohols and Ketones

1997 920 citations Akio Fujii et al. profile →
Asymmetric Transfer Hydrogenation of Imines

1996 723 citations Akio Fujii et al. profile →
Kinetic Resolution of Racemic Secondary Alcohols by Ru^II‐Catalyzed Hydrogen Transfer

1997 327 citations Akio Fujii et al. profile →
Amino alcohol effects on the ruthenium(II)-catalysed asymmetric transfer hydrogenation of ketones in propan-2-ol

1996 277 citations Akio Fujii et al. profile →
Katalysatorvorstufe, Katalysator und Zwischenstufe des Ru^II‐katalysierten, asymmetrischen Wasserstofftransfers zwischen Alkoholen und Ketonen

1997 235 citations Akio Fujii et al. profile →

Peers

Countries citing papers authored by Akio Fujii

Since Specialization

Citations

This map shows the geographic impact of Akio Fujii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akio Fujii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akio Fujii more than expected).

Fields of papers citing papers by Akio Fujii

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akio Fujii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akio Fujii. The network helps show where Akio Fujii may publish in the future.

Co-authorship network of co-authors of Akio Fujii

This figure shows the co-authorship network connecting the top 25 collaborators of Akio Fujii. A scholar is included among the top collaborators of Akio Fujii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akio Fujii. Akio Fujii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Renal adenomatosis associated with carcinoma of the lower urinary tract: A case report with immunohistochemical study 1999 ·Pathology International ·Tomohiko Kizaki, (unknown), Hiroshi Hirano, Kazuo Gohji, Akio Fujii	6
2	Conservative therapy for stage T1b, grade 3 transitional cell carcinoma of the bladder 1999 ·Urology ·Kazuo Gohji, Masashi Nomi, Masayuki Okamoto, Atsushi Takenaka, Isao Hara, Hiroshi Okada, Soichi Arakawa, Akio Fujii, Sadao Kamidono	46
3	Results of Transurethral Resection Plus Adjuvant Intravesical Chemotherapy for Superficial Bladder Cancer 1998 ·International Journal of Urology ·Masashi Nomi, Kazuo Gohji, Masayuki Okamoto, (unknown), (unknown), Akio Fujii	3
4	Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension 1998 ·International Journal of Cancer ·Kazuo Gohji, Noboru Fujimoto, Isao Hara, Akio Fujii, (unknown), Hiroshi Okada, (unknown), Sohei Kitazawa, H. Miyake, Sadao Kamidono, Motowo Nakajima	112
5	Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations 1997 ·Cancer ·Kazuo Gohji, Masashi Nomi, Shin Egawa, (unknown), Atsushi Takenaka, Masayuki Okamoto, Makoto Ohori, Akio Fujii	41
6	Inferior Vena Cava Filter Used for Unresectable Renal Cell Carcinoma with Tumor Thrombi 1996 ·International Journal of Urology ·Kazuo Gohji, (unknown), (unknown), Masashi Nomi, Akio Fujii, Sadao Kamidono	0
7	USEFULNESS OF DIGITAL RECTAL EXAMINATION, SERUM PROSTATE‐SPECIFIC ANTIGEN, TRANSRECTAL ULTRAS ONOGRAPHY AND SYSTEMATIC PROSTATE BIOPSY FOR THE DETECTION OF ORGAN‐CONFINED PROSTATE CANCER 1995 ·International Journal of Urology ·Kazuo Gohji, Masayuki Okamoto, (unknown), Akio Fujii	5
8	Malignant gonadal stromal tumor 1994 ·Urology ·Kazuo Gohji, Akihiro Higuchi, Akio Fujii, Tomohiko Kizaki	14
9	KOCK-RECTAL BLADDER 1992 ·The Japanese Journal of Urology ·Akio Fujii, (unknown), (unknown), Akihiro Higuchi, (unknown), Norio Kôno, Yoshio ISHIKAWA	0
10	Deoxyspergualin, a novel immunosuppressant, markedly inhibits human mixed lymphocyte reaction and cytotoxic T-lymphocyte activity in vitro 1992 ·International Journal of Immunopharmacology ·Hideji Fujii, (unknown), Kyuichi Nemoto, Fuminori Abe, Akio Fujii, James E. Talmadge, TOMIO TAKEUCHI	28
11	COMBINATION CHEMOTHERAPY WITH METHOTREXATE, VINCRISTINE, CISPLATINUM, CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND BLEOMYCIN (MVP-CAB) FOR METASTATIC UROTHELIAL CANCER 1991 ·The Japanese Journal of Urology ·Akio Fujii, (unknown), (unknown), Akihiro Higuchi, Noboru Itoh, Yasuyuki Okamoto, Hiroyuki Tanaka, (unknown), (unknown), Takao Inoué, (unknown), (unknown), Yuji Yamada, (unknown), Shinichi Morishita, (unknown), Ichiro Nakamura	1
12	An additive problem of prime numbers, II 1991 ·Proceedings of the Japan Academy Series A Mathematical Sciences ·Akio Fujii	10
13	PREOPERATIVE ADJUVANT THERAPY FOR URINARY BLADDER CANCER 1990 ·The Japanese Journal of Urology ·Kazuo Gohji, (unknown), Soichi Arakawa, Osamu Matsumoto, Sadao Kamidono, Akio Fujii, Shinichi Morishita, (unknown), (unknown), Gaku Hamami, (unknown), (unknown), (unknown), (unknown)	2
14	Deoxyspergualin directly suppresses antibody formation in vivo and in vitro. 1990 ·The Journal of Antibiotics ·Hideji Fujii, (unknown), Kyuichi Nemoto, (unknown), Fuminori Abe, Akio Fujii, TOMIO TAKEUCHI	51
15	In vitro immunosuppressive properties of spergualins to murine T cell response. 1989 ·The Journal of Antibiotics ·Hideji Fujii, (unknown), (unknown), Fuminori Abe, Akio Fujii, (unknown)	40
16	In vivo effects of deoxyspergualin (NKT-01) on lymphocyte activation in response to alloantigens. 1988 ·The Journal of Antibiotics ·Yoshie Yoshikawa, Hiroyuki Uchida, Hiroyuki Kuroda, Teruya Nakamura, Akira Ôbayashi, Akio Fujii, (unknown)	7
17	Synthesis and biological activity of spergualin analogues. I. 1988 ·The Journal of Antibiotics ·RINZO NISHIZAWA, (unknown), Masao Yoshida, (unknown), Tetsushi Saino, Kiyohiro Nishikawa, Kyuichi Nemoto, Katsutoshi Takahashi, Akio Fujii, Teruya Nakamura, TOMOHISA TAKITA, TOMIO TAKEUCHI	8
18	Derivatives of oxetanocin: Oxetanocins H, X and G, and 2-aminooxetanocin A. 1987 ·The Journal of Antibiotics ·NOBUYOSHI SHIMADA, Shigeru Hasegawa, Seiichi Saito, Takaaki Nishikiori, Akio Fujii, TOMOHISA TAKITA	38
19	Synthesis and antitumor activity of spergualin analogues. II. Chemical modification of the spermidine moiety. 1987 ·The Journal of Antibiotics ·YOSHIHISA UMEDA, (unknown), Hiroyuki Kuroda, Teruya Nakamura, Akio Fujii, HIRONOBU IINUMA, TOMIO TAKEUCHI, HAMAO UMEZAWA	12
20	SYMPOSIUM ON MODE OF RESISTANCE AND STRUCTURE-ACTIVITY 1968 ·Japanese Journal of Medical Science and Biology ·HAMAO UMEZAWA, Kenji Maeda, Akio Fujii, Shinichi Kondo, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact